Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Archives of Medical Sciences. Atherosclerotic Diseases|September 15, 2017
Estimating fat mass in heart failure patientsTobias Daniel Trippel, Julian Lenk, Hanns-Christian Gunga, et al.
Metabolites|September 26, 2021
Lipid Metabolite Biomarkers in Cardiovascular Disease: Discovery and Biomechanism Translation from Human StudiesPeter McGranaghan, Jennifer A Kirwan, Mariel A Garcia-Rivera, et al.
ESC Heart Failure|February 10, 2021
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF studyTobias Daniel Trippel, Meinhard Mende, Hans-Dirk Düngen, et al.
ESC Heart Failure|December 9, 2020
Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fractionCaterina Maffeis, Daniel Armando Morris, Evgeny Belyavskiy, et al.
Scientific Reports|April 15, 2021
Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failurePeter McGranaghan, Anshul Saxena, Hans-Dirk Düngen, et al.
Biomarkers in Medicine|October 30, 2019
Early NT-proBNP and MR-proANP associated with QoL 1 year after acutely decompensated heart failure: secondary analysis from the MOLITOR trialChristine Zelenak, Mira-Lynn Chavanon, Elvis Tahirovic, et al.
ESC Heart Failure|February 21, 2017
Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot studyTobias Daniel Trippel, Volker Holzendorf, Martin Halle, et al.
Jmirx Med|November 5, 2025
Assessing the Limitations of Large Language Models in Clinical Practice Guideline-Concordant Treatment Decision-Making on Real-World Data: Retrospective StudyTobias Roeschl, Marie Hoffmann, Djawid Hashemi, et al.
ESC Heart Failure|August 30, 2020
Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patientsPeter McGranaghan, Hans-Dirk Düngen, Anshul Saxena, et al.
European Journal of Heart Failure|September 12, 2017
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)Tobias Daniel Trippel, Sophie Van Linthout, Dirk Westermann, et al.
Pageof 3